Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Vista Pharmaceuticals Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹7.74 |
|---|---|
| Day's Range | ₹6.85 - ₹7.76 |
| Open | ₹6.85 |
| 52 Week Range | ₹05.71 - ₹12.01 |
| Volume | 19,741 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1.53 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -1.25 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 1.06 |
| PAT Margin (%) | -46.14 |
| Face Value (₹) | 2.00 |
| ROCE(%) | -8.54 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 25.55 | 102.88 |
| Expenses | N/A | N/A |
| PBT | -18.04 | -51.78 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -13.22 | -45.12 |
About Vista Pharmaceuticals Ltd.
| Founded | 1991 |
|---|---|
| Managing Director | Murali Meraga |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,41,789.55 | 1,829.45 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,79,450.12 | 6,724.90 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,54,733.87 | 4,420.85 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,20,848.85 | 8,275.35 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,14,182.61 | 1,414.95 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,184.65 | 1,333.30 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,07,973.94 | 1,076.95 | 835.50 - 835.50 |
| Lupin Ltd. | 1,04,613.28 | 2,252.80 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,01,443.53 | 2,420.20 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 97,382.77 | 996.00 | 903.00 - 903.00 |
No Records Found
Latest News
May
26
2026
Posted on May 26th 2026
Blue Jet Healthcare - Quaterly Results
The sales is pegged at Rs. 2346.68 millions for the March 2026 quarter. The mentioned figure indicates a decline of about -31.07% as against Rs. 3404.45 millions during the year-ago period.Net profit of the cmpany stood at Rs. 643.44 millions for the quarter ended March 2026 a decline of -41.56% from Rs. 1100.95 millions in the same quarter last year.Operating profit for the quarter ended March 2026 decreased to 941.87 millions as compared to 1521.93 millions of corresponding quarter ended March 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 2346.68 | 3404.45 | -31.07 | 9473.21 | 10299.85 | -8.03 | 9473.21 | 10299.85 | -8.03 |
| Other Income | 229.20 | 122.25 | 87.48 | 686.54 | 462.56 | 48.42 | 686.54 | 462.56 | 48.42 |
| PBIDT | 941.87 | 1521.93 | -38.11 | 3627.53 | 4239.86 | -14.44 | 3627.53 | 4239.86 | -14.44 |
| Interest | 5.83 | 0.34 | 1614.71 | 62.39 | 0.98 | 6266.33 | 62.39 | 0.98 | 6266.33 |
| PBDT | 936.04 | 1521.59 | -38.48 | 3565.14 | 4238.88 | -15.89 | 3565.14 | 4238.88 | -15.89 |
| Depreciation | 64.55 | 49.47 | 30.48 | 240.02 | 177.89 | 34.93 | 240.02 | 177.89 | 34.93 |
| PBT | 871.49 | 1472.12 | -40.80 | 3325.12 | 4060.99 | -18.12 | 3325.12 | 4060.99 | -18.12 |
| TAX | 228.05 | 371.17 | -38.56 | 846.96 | 1008.96 | -16.06 | 846.96 | 1008.96 | -16.06 |
| Deferred Tax | 12.15 | 3.42 | 255.26 | 34.06 | 41.21 | -17.35 | 34.06 | 41.21 | -17.35 |
| PAT | 643.44 | 1100.95 | -41.56 | 2478.16 | 3052.03 | -18.80 | 2478.16 | 3052.03 | -18.80 |
| Equity | 346.93 | 346.93 | 0.00 | 346.93 | 346.93 | 0.00 | 346.93 | 346.93 | 0.00 |
| PBIDTM(%) | 40.14 | 44.70 | -10.22 | 38.29 | 41.16 | -6.98 | 38.29 | 41.16 | -6.98 |
Read More
May
26
2026
Posted on May 26th 2026
Guj. Themis Biosyn - Quaterly Results
The Revenue for the quarter ended March 2026 of Rs. 442.33 millions grew by 17.22 % from Rs. 377.36 millions.Net profit declined -9.22% to Rs. 108.91 millions from Rs. 119.97 millions.The company reported a good operating profit of 202.81 millions compared to 173.86 millions of corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 442.33 | 377.36 | 17.22 | 1658.23 | 1508.00 | 9.96 | 1658.23 | 1508.00 | 9.96 |
| Other Income | 9.21 | 13.48 | -31.68 | 24.28 | 24.32 | -0.16 | 24.28 | 24.32 | -0.16 |
| PBIDT | 202.81 | 173.86 | 16.65 | 779.58 | 712.76 | 9.37 | 779.58 | 712.76 | 9.37 |
| Interest | 19.06 | 0.71 | 2584.51 | 29.49 | 3.64 | 710.16 | 29.49 | 3.64 | 710.16 |
| PBDT | 183.75 | 173.15 | 6.12 | 750.09 | 709.12 | 5.78 | 750.09 | 709.12 | 5.78 |
| Depreciation | 40.38 | 12.28 | 228.83 | 129.19 | 53.75 | 140.35 | 129.19 | 53.75 | 140.35 |
| PBT | 143.37 | 160.87 | -10.88 | 620.90 | 655.37 | -5.26 | 620.90 | 655.37 | -5.26 |
| TAX | 34.46 | 40.90 | -15.75 | 154.08 | 167.66 | -8.10 | 154.08 | 167.66 | -8.10 |
| Deferred Tax | 10.70 | 2.32 | 361.21 | 46.22 | 2.80 | 1550.71 | 46.22 | 2.80 | 1550.71 |
| PAT | 108.91 | 119.97 | -9.22 | 466.82 | 487.71 | -4.28 | 466.82 | 487.71 | -4.28 |
| Equity | 108.97 | 108.97 | 0.00 | 108.97 | 108.97 | 0.00 | 108.97 | 108.97 | 0.00 |
| PBIDTM(%) | 45.85 | 46.07 | -0.48 | 47.01 | 47.27 | -0.53 | 47.01 | 47.27 | -0.53 |
Read More
May
26
2026
Posted on May 26th 2026
Yatharth Hospital - Quaterly Results
The sales figure stood at Rs. 1638.71 millions for the March 2026 quarter. The mentioned figure indicates a growth of about 45.65% as compared to Rs. 1125.07 millions during the year-ago period.A humble growth in net profit of 8.49% reported in the quarter ended March 2026 to Rs. 237.56 millions from Rs. 218.96 millions.Operating profit surged to 459.45 millions from the corresponding previous quarter of 358.74 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 1638.71 | 1125.07 | 45.65 | 5918.84 | 4564.84 | 29.66 | 5918.84 | 4564.84 | 29.66 |
| Other Income | 67.64 | 35.83 | 88.78 | 232.10 | 94.49 | 145.63 | 232.10 | 94.49 | 145.63 |
| PBIDT | 459.45 | 358.74 | 28.07 | 1633.74 | 1387.10 | 17.78 | 1633.74 | 1387.10 | 17.78 |
| Interest | 44.77 | 1.53 | 2826.14 | 57.31 | 6.16 | 830.36 | 57.31 | 6.16 | 830.36 |
| PBDT | 414.68 | 357.21 | 16.09 | 1576.43 | 1380.94 | 14.16 | 1576.43 | 1380.94 | 14.16 |
| Depreciation | 104.54 | 47.09 | 122.00 | 304.59 | 186.63 | 63.21 | 304.59 | 186.63 | 63.21 |
| PBT | 310.14 | 310.12 | 0.01 | 1271.84 | 1194.31 | 6.49 | 1271.84 | 1194.31 | 6.49 |
| TAX | 72.58 | 91.16 | -20.38 | 317.74 | 317.39 | 0.11 | 317.74 | 317.39 | 0.11 |
| Deferred Tax | 4.45 | 1.66 | 168.07 | 13.58 | 2.69 | 404.83 | 13.58 | 2.69 | 404.83 |
| PAT | 237.56 | 218.96 | 8.49 | 954.10 | 876.92 | 8.80 | 954.10 | 876.92 | 8.80 |
| Equity | 963.54 | 963.54 | 0.00 | 963.54 | 963.54 | 0.00 | 963.54 | 963.54 | 0.00 |
| PBIDTM(%) | 28.04 | 31.89 | -12.07 | 27.60 | 30.39 | -9.16 | 27.60 | 30.39 | -9.16 |
Read More
May
26
2026
Posted on May 26th 2026
Chennai Meena Multi - Quaterly Results
The Revenue for the quarter ended March 2026 of Rs. 98.10 millions grew by 7.00 % from Rs. 91.68 millions.The Net Loss for the quarter ended March 2026 is Rs. -0.21 millions as compared to Net Profit of Rs. 3.14 millions of corresponding quarter ended March 2025The Operating Profit of the company witnessed a decrease to 4.83 millions from 7.69 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 98.10 | 91.68 | 7.00 | 370.39 | 348.18 | 6.38 | 370.39 | 348.18 | 6.38 |
| Other Income | 2.39 | 4.23 | -43.50 | 11.18 | 8.54 | 30.91 | 11.18 | 8.54 | 30.91 |
| PBIDT | 4.83 | 7.69 | -37.19 | 8.42 | 6.49 | 29.74 | 8.42 | 6.49 | 29.74 |
| Interest | 2.27 | 2.24 | 1.34 | 8.98 | 9.13 | -1.64 | 8.98 | 9.13 | -1.64 |
| PBDT | 2.56 | 5.45 | -53.03 | -0.56 | -2.64 | -78.79 | -0.56 | -2.64 | -78.79 |
| Depreciation | 2.58 | 2.26 | 14.16 | 10.91 | 11.64 | -6.27 | 10.91 | 11.64 | -6.27 |
| PBT | -0.02 | 3.19 | -100.63 | -11.47 | -14.28 | -19.68 | -11.47 | -14.28 | -19.68 |
| TAX | 0.19 | 0.05 | 280.00 | -0.30 | -0.54 | -44.44 | -0.30 | -0.54 | -44.44 |
| Deferred Tax | 0.19 | 0.05 | 280.00 | -0.30 | -0.54 | -44.44 | -0.30 | -0.54 | -44.44 |
| PAT | -0.21 | 3.14 | -106.69 | -11.17 | -13.74 | -18.70 | -11.17 | -13.74 | -18.70 |
| Equity | 74.69 | 74.69 | 0.00 | 74.69 | 74.69 | 0.00 | 74.69 | 74.69 | 0.00 |
| PBIDTM(%) | 4.92 | 8.39 | -41.30 | 2.27 | 1.86 | 21.96 | 2.27 | 1.86 | 21.96 |
Read More
May
26
2026
Posted on May 26th 2026
Lyka Labs - Quaterly Results
The sales declined to Rs. 280.31 millions for the March 2026 quarter as compared to Rs. 305.17 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2026 is Rs. -297.71 millions as compared to Net Profit of Rs. 12.31 millions of corresponding quarter ended March 2025Operating profit Margin for the quarter ended March 2026 slipped to -39.72% as compared to 41.20% of corresponding quarter ended March 2025
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 280.31 | 305.17 | -8.15 | 1209.05 | 1346.97 | -10.24 | 1209.05 | 1346.97 | -10.24 |
| Other Income | 5.10 | 8.22 | -37.96 | 39.74 | 27.60 | 43.99 | 39.74 | 27.60 | 43.99 |
| PBIDT | -39.72 | 41.20 | -196.41 | 15.66 | 201.72 | -92.24 | 15.66 | 201.72 | -92.24 |
| Interest | 8.73 | 5.20 | 67.88 | 33.27 | 23.05 | 44.34 | 33.27 | 23.05 | 44.34 |
| PBDT | -278.59 | 36.00 | -873.86 | -247.75 | 178.67 | -238.66 | -247.75 | 178.67 | -238.66 |
| Depreciation | 20.44 | 14.17 | 44.25 | 84.60 | 67.66 | 25.04 | 84.60 | 67.66 | 25.04 |
| PBT | -299.03 | 21.83 | -1469.81 | -332.35 | 111.01 | -399.39 | -332.35 | 111.01 | -399.39 |
| TAX | -1.32 | 9.52 | -113.87 | -9.47 | 31.83 | -129.75 | -9.47 | 31.83 | -129.75 |
| Deferred Tax | -4.70 | 2.76 | -270.29 | -17.75 | 4.57 | -488.40 | -17.75 | 4.57 | -488.40 |
| PAT | -297.71 | 12.31 | -2518.44 | -322.88 | 79.18 | -507.78 | -322.88 | 79.18 | -507.78 |
| Equity | 356.90 | 356.90 | 0.00 | 356.90 | 356.90 | 0.00 | 356.90 | 356.90 | 0.00 |
| PBIDTM(%) | -14.17 | 13.50 | -204.96 | 1.30 | 14.98 | -91.35 | 1.30 | 14.98 | -91.35 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Vista Pharmaceuticals Ltd. is ₹7.74 as of 2026-05-26.
The market capitalisation of Vista Pharmaceuticals Ltd. is ₹44.75 as of 2026-05-25.
The 1-year return of Vista Pharmaceuticals Ltd. is -3.16% as of 2025-05-23.
The P/E ratio of Vista Pharmaceuticals Ltd. is 0.00 as of 2026-05-26.
The 52-week high and low of Vista Pharmaceuticals Ltd. are ₹12.01 and ₹5.71, respectively, as of 2026-05-26.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
